Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(8.5%),New Enterprise Associates 15, L.P.(8.5%), etc.
Addex Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(8.5%),New Enterprise Associates 15, L.P.(8.5%)等
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間